Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 10(4): e0122838, 2015.
Article in English | MEDLINE | ID: mdl-25835954

ABSTRACT

INTRODUCTION: Maintenance of high tissue oxygenation (PtO2) is recommended during surgery because PtO2 is highly predictive of surgical site infection and colonic anastomotic leakage. However, surgical site perfusion is often sub-optimal, creating an obstructive hurdle for traditional, systemically applied therapies to maintain or increase surgical site PtO2. This research tested the hypothesis that insufflation of humidified-warm CO2 into the abdominal cavity would increase sub-peritoneal PtO2 during open abdominal surgery. MATERIALS AND METHODS: 15 Wistar rats underwent laparotomy under general anesthesia. Three sets of randomized cross-over experiments were conducted in which the abdominal cavity was subjected to alternating exposure to 1) humidified-warm CO2 & ambient air; 2) humidified-warm CO2 & dry-cold CO2; and 3) dry-cold CO2 & ambient air. Sub-peritoneal PtO2 and tissue temperature were measured with a polarographic oxygen probe. RESULTS: Upon insufflation of humidified-warm CO2, PtO2 increased by 29.8 mmHg (SD 13.3; p<0.001), or 96.6% (SD 51.9), and tissue temperature by 3.0°C (SD 1.7 p<0.001), in comparison with exposure to ambient air. Smaller, but significant, increases in PtO2 were seen in experiments 2 and 3. Tissue temperature decreased upon exposure to dry-cold CO2 compared with ambient air (-1.4°C, SD 0.5, p = 0.001). CONCLUSIONS: In a rat model, insufflation of humidified-warm CO2 into the abdominal cavity during open abdominal surgery causes an immediate and potentially clinically significant increase in PtO2. The effect is an additive result of the delivery of CO2 and avoidance of evaporative cooling via the delivery of the CO2 gas humidified at body temperature.


Subject(s)
Carbon Dioxide/administration & dosage , Humidity , Laparotomy/methods , Oxygen/metabolism , Animals , Body Temperature , Female , Intraoperative Period , Random Allocation , Rats , Rats, Wistar
2.
J Innate Immun ; 6(2): 240-50, 2014.
Article in English | MEDLINE | ID: mdl-23969887

ABSTRACT

The globally significant human pathogen group A Streptococcus (GAS) sequesters the host protease plasmin to the cell surface during invasive disease initiation. Recent evidence has shown that localized plasmin activity prevents opsonization of several bacterial species by key components of the innate immune system in vitro. Here we demonstrate that plasmin at the GAS cell surface resulted in degradation of complement factor C3b, and that plasminogen acquisition is associated with a decrease in C3b opsonization and neutrophil-mediated killing in vitro. Furthermore, the ability to acquire cell surface plasmin(ogen) correlates directly with a decrease in C3b opsonization, neutrophil phagocytosis, and increased bacterial survival in a humanized plasminogen mouse model of infection. These findings demonstrate that localized plasmin(ogen) plays an important role in facilitating GAS escape from the host innate immune response and increases bacterial virulence in the early stages of infection.


Subject(s)
Complement C3b/immunology , Neutrophils/immunology , Phagocytosis/immunology , Plasminogen/immunology , Streptococcus pyogenes/immunology , Animals , Blotting, Western , Complement C3b/metabolism , Female , Fibrinolysin/immunology , Fibrinolysin/metabolism , Flow Cytometry , Host-Pathogen Interactions/immunology , Humans , Immune Evasion/immunology , Male , Mice, Transgenic , Neutrophils/metabolism , Neutrophils/microbiology , Plasminogen/genetics , Plasminogen/metabolism , Streptococcal Infections/genetics , Streptococcal Infections/immunology , Streptococcal Infections/microbiology , Streptococcus pyogenes/metabolism , Streptococcus pyogenes/physiology , Streptokinase/immunology , Streptokinase/metabolism
3.
Infect Immun ; 77(5): 1817-26, 2009 May.
Article in English | MEDLINE | ID: mdl-19223478

ABSTRACT

Live-vaccine delivery systems expressing two model antigens from Mycoplasma hyopneumoniae, F2(P97) (Adh) and NrdF, were constructed using Salmonella enterica serovar Typhimurium aroA (STM-1), and immunogenicity in mice was evaluated. Recombinant plasmid-based expression (PBE) and chromosomally based expression (CBE) systems were constructed. The PBE system was formed by cloning both antigen genes into pJLA507 to create an operon downstream of temperature-inducible promoters. Constitutive CBE was achieved using a promoter-trapping technique whereby the promoterless operon was stably integrated into the chromosome of STM-1, and the expression of antigens was assessed. The chromosomal position of the operon was mapped in four clones. Inducible CBE was obtained by using the in vivo-induced sspA promoter and recombining the expression construct into aroD. Dual expression of the antigens was detected in all systems, with PBE producing much larger quantities of both antigens. The stability of antigen expression after in vivo passage was 100% for all CBE strains recovered. PBE and CBE strains were selected for comparison in a vaccination trial. The vaccine strains were delivered orally into mice, and significant systemic immunoglobulin M (IgM) and IgG responses against both antigens were detected among all CBE groups. No significant immune response was detected using PBE strains. Expression of recombinant antigens in S. enterica serovar Typhimurium aroA from chromosomally located strong promoters without the use of antibiotic resistance markers is a reliable and effective method of inducing a significant immune response.


Subject(s)
Bacterial Vaccines/genetics , Bacterial Vaccines/immunology , Genetic Vectors , Mycoplasma hyopneumoniae/immunology , Salmonella typhimurium/genetics , Administration, Oral , Animals , Antibodies, Bacterial/blood , Chromosome Mapping , Chromosomes, Bacterial , Female , Gene Expression Profiling , Gene Order , Immunoglobulin M/blood , Mice , Mice, Inbred BALB C , Mycoplasma hyopneumoniae/genetics , Plasmids , Salmonella typhimurium/immunology , Typhoid-Paratyphoid Vaccines/genetics , Typhoid-Paratyphoid Vaccines/immunology , Vaccines, Attenuated/genetics , Vaccines, Attenuated/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...